个人简介
Education Background:
Doctoral degree| Academy of Military Medical Sciences, Beijing, Chi| 2006
Positions & Employments:
2002.9- Tianjin University | Associate Professor
1999.9-2002.6 City College, City University of New York (CUNY) | Research associate
1994.9-1999.6 Hunter Colllege, CUNY | Research assistant,
1989.9-1991.6 Capital Institute of Medicine (Beijing, China) | Assistant Professor
Honors & Awards:
2015 Tianjin best advisor for PSIP (Project of Student Innovation and Practice)
研究领域
Several peptibodies inhibiting B lymphocyte stimulator (BLyS), a critical factor for B cell maturation and survival, are currently tested in cell culture and SLE animal models in this lab.
The strategy in this group is to design cytokine antagonist peptides using computer-aided design, fuse the peptides with human IgG Fc to form peptibodies by gene engineering, and analyze their activity in vitro and in vivo.
Because overexpression of BLyS is involved in pathogenesis and development of autoimmune diseases and B cell malignances, the BLyS antagonists designed and analyzed may be potential therapeutic reagents for these diseases.
The research in the group of Sun involves investigation of B cell development and B cell related diseases. In recent years, immunotherapies with antibodies to depleting B cells are widely used in autoimmune diseases and B cell lymphoma.
近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Jiang, Y., Sun, J. & Wei, J. Distinct binding mode of BAFF antagonist antibodies belimumab and tabalumab, analyzed by computer simulation. J Mol Model 28, 292 (2022). https://doi.org/10.1007/s00894-022-05142-7
New therapeutic strategies based on biasing IL-2 mutants for cancers and autoimmune diseases
Jin Dongfu,Jiang Yaxin,Chang Lu,Wei Jing,Sun Jian
Page:108935 ISSN:1567-5769 2022
Container-title:International Immunopharmacology
Subcellular Proteome Analysis Reveals Apoptotic Vulnerability of T-Cell Acute Lymphoblastic Leukemia
BioMed Research International
2022-04-15 | Journal article | Author
DOI: 10.1155/2022/5504475
Part of ISSN: 2314-6141
Part of ISSN: 2314-6133
CONTRIBUTORS: Xiaolei Song; xiaojing wu; zhang zihan; Cui zhangxiu; Yong Zheng; jian sun
Analysis of the molecular mechanism of SARS-CoV-2 antibodies
Jin Dongfu,Wei Jing,Sun Jian
Page:45-52 ISSN:0006-291X 2021
Container-title:Biochemical and Biophysical Research Communications
Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy
Zhao Haodi,Wei Jing,Sun Jian
Page:107101 ISSN:1567-5769 2020
Container-title:International Immunopharmacology
Overview of anti-BCMA CAR-T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma
Deming Feng, Jian Sun
First published: 29 May 2020 https://doi.org/10.1111/sji.12910
Study on the Mechanism of Selective Interaction of BR3 and BCMA with BAFF and APRIL
Protein & Peptide Letters
2020-11-16 | Journal article
DOI: 10.2174/0929866527666200413101757
CONTRIBUTORS: Luoman Li; Yaxin Jiang; LiLi Su; Deming Feng; Jing Wei; Jian Sun
Synergetic estrogen receptor-targeting liposome nanocarriers with anti-phagocytic properties for enhanced tumor theranostics
Journal of Materials Chemistry B
2019 | Journal article
DOI: 10.1039/C8TB03351J
CONTRIBUTORS: Yuehua Wang; Zihua Wang; Yixia Qian; Linyang Fan; Chunyan Yue; Fei Jia; Jian Sun; Zhiyuan Hu; Weizhi Wang
Boosting the Theranostic Effect of Liposomal Probes toward Prominin-1 through Optimized Dual-Site Targeting
Analytical Chemistry
2019-06-04 | Journal article
DOI: 10.1021/acs.analchem.9b00622
CONTRIBUTORS: Yuehua Wang; Fei Jia; Zihua Wang; Yixia Qian; Linyang Fan; He Gong; Aiqin Luo; Jian Sun; Zhiyuan Hu; Weizhi Wang
Construction of small molecular CTLA4 analogs with CD80-binding affinity
Liu Fang,Su LiLi,Chen Ziteng,Feng Deming,Wei Jing,Sun Jian
Page:694-700 ISSN:0006-291X 2019
Container-title:Biochemical and Biophysical Research Communications